Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
Status:
Unknown status
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effect of metformin on biochemical and
histological findings in NAFLD patients with insulin resistance syndrome.